Ali Behbahani Insider Trading $ADAP Adaptimmune Therapeutics PLC
Get free email notifications about insider trading for Ali Behbahani.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Ali Behbahani. Ali Behbahani is 10% Owner in Marker Therapeutics, Inc. ($MRKR) and Director in NEVRO CORP ($NVRO) and Director in GENOCEA BIOSCIENCES, INC. ($GNCA) and 10% Owner in Regulus Therapeutics Inc. ($RGLS) and 10% Owner in Trevi Therapeutics, Inc. ($TRVI) and Director in Adaptimmune Therapeutics PLC ($ADAP) and 10% Owner in Metacrine, Inc. ($MTCR) and Director in CRISPR Therapeutics AG ($CRSP) and Director in Black Diamond Therapeutics, Inc. ($BDTX) and Director in Oyster Point Pharma, Inc. ($OYST) and 10% Owner in Akouos, Inc. ($AKUS) and 10% Owner in Mirum Pharmaceuticals, Inc. ($MIRM) and Director in Nkarta, Inc. ($NKTX).
Ali Behbahani in Adaptimmune Therapeutics PLC
Trading Symbol: ADAPIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Ali Behbahani: Director
Holdings: 19,500,000 shares
Current Value: $88,335,000
Latest Transaction: Jul 01 2020
$ADAP Market Capitalization: $321.36M
$ADAP Previous Close: $4.53
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Ali Behbahani in Adaptimmune Therapeutics PLC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADAP, AKUS, BDTX, CRSP, GNCA, MRKR, MTCR, MIRM, NVRO, NKTX, OYST, RGLS, TRVI
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 01 2020 | ADAP | Adaptimmune Therap ... | Behbahani Ali | Director | Option Exercise | A | 1.67 | 184,258 | 307,711 | 184,258 | |
Jan 28 2020 | ADAP | Adaptimmune Therap ... | Behbahani Ali | Director | Buy | P | 0.67 | 7,500,000 | 5,000,250 | 19,500,000 | 12 M to 19.5 M (+62.50 %) |
Jul 03 2019 | ADAP | Adaptimmune Therap ... | Behbahani Ali | Director | Option Exercise | A | 0.61 | 234,407 | 142,988 | 234,407 | |
Sep 10 2018 | ADAP | Adaptimmune Therap ... | Behbahani Ali | Director | Buy | P | 1.67 | 12,000,000 | 20,000,400 | 12,000,000 | 0 to 12 M |
Jun 26 2018 | ADAP | Adaptimmune Therap ... | Behbahani Ali | Director | Option Exercise | A | 2.18 | 154,809 | 337,484 | 154,809 | |
Jul 03 2017 | ADAP | Adaptimmune Therap ... | Behbahani Ali | Director | Option Exercise | A | 0.75 | 220,788 | 165,591 | 220,788 | |
Aug 12 2016 | ADAP | Adaptimmune Therap ... | Behbahani Ali | Director | Option Exercise | A | 1.27 | 184,562 | 234,394 | 184,562 |
Page: 1